Media room

This section features official updates, announcements, press releases, and key highlights from our brand. Stay informed about company milestones, partnerships, and important media coverage.

a phone with a pay pay logo on it

PayPal’s AI Pivot: $1.5B Savings Through Tech Overhaul

PayPal is charting a new course by embracing artificial intelligence as the centerpiece of its corporate reinvention, positioning itself as a technology-first organization. The fintech giant aims to unlock $1.5 billion in operational savings through automation, workforce optimization, and a comprehensive modernization of its aging technology systems.

PayPal’s AI Pivot: $1.5B Savings Through Tech Overhaul Read More »

Diverse team celebrating success at office desk.

SurveyMonkey’s Values Recognition Program Transforms Workplace Culture

SurveyMonkey has introduced a groundbreaking “Living Our Values” survey that empowers employees to recognize peers who exemplify company values, resulting in a remarkable 23-point increase in cultural alignment. The initiative offers small business owners a practical blueprint for transforming abstract company values into tangible, lived experiences that boost engagement and retention.

SurveyMonkey’s Values Recognition Program Transforms Workplace Culture Read More »

girl and boy playing on bed

Norgine’s PEDMARQSI Approved in Australia for Child Cancer Patients

Norgine has secured regulatory approval from Australia’s TGA for PEDMARQSI, a groundbreaking treatment designed to protect children undergoing cisplatin chemotherapy from permanent hearing damage. This milestone addresses a critical gap in pediatric oncology care where chemotherapy-related hearing loss has long posed a significant challenge to quality of life.

Norgine’s PEDMARQSI Approved in Australia for Child Cancer Patients Read More »

girl and boy playing on bed

Norgine’s PEDMARQSI Approved in Australia for Child Hearing Protection

Norgine has achieved a significant regulatory milestone with the Australian TGA’s approval of PEDMARQSI® (anhydrous sodium thiosulfate) for protecting children from chemotherapy-related hearing damage. The approval marks an important advancement in pediatric oncology care, offering hope to young cancer patients undergoing cisplatin treatment.

Norgine’s PEDMARQSI Approved in Australia for Child Hearing Protection Read More »

Hand holding a gold american express card near laptop.

Lidl Loyalty Scheme Overhaul Leaves Shoppers Disappointed

Lidl has fundamentally restructured its customer loyalty program, moving from traditional reward coupons to a points-based system that critics argue delivers fewer tangible benefits. The supermarket chain’s new approach, which awards one point per pound spent, has already drawn scrutiny from regular shoppers questioning whether they’re getting fair value.

Lidl Loyalty Scheme Overhaul Leaves Shoppers Disappointed Read More »

a woman in a white shirt holding a red ribbon

Norgine’s PEDMARQSI Wins Australian TGA Approval

Norgine has achieved a significant regulatory milestone with the Australian Therapeutic Goods Administration (TGA) approving PEDMARQSI® (anhydrous sodium thiosulfate) for preventing cisplatin-induced hearing loss in pediatric patients. This approval marks an important advancement in protecting young cancer patients from ototoxicity, a serious side effect of chemotherapy.

Norgine’s PEDMARQSI Wins Australian TGA Approval Read More »